Showing results (1-10 of 110) with videos related to
Sort By:
Pageof 11
American Journal of Ophthalmology|March 8, 2000
Tissue plasminogen activator to treat impending pupillary block glaucoma in patients with acute fibrinous HLA-B27 positive iridocyclitisC A Skolnick, R G Fiscella, H H Tessler, et al.Investigative Ophthalmology & Visual Science|March 1, 1996
Intraocular penetration of periocular ketorolac and efficacy in experimental uveitisP K Rabiah, R G Fiscella, H H TesslerClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 7, 2001
Acute endogenous endophthalmitis due to Bartonella henselaeD A Goldstein, L Mouritsen, S Friedlander, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|September 25, 1998
Ocular manifestations of Whipple disease: an atypical presentationJ G Williams, D P Edward, H H Tessler, et al.The British Journal of Ophthalmology|February 1, 1989
Twenty cases of sympathetic ophthalmiaT Jennings, H H TesslerCanadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|April 1, 1993
Quadruple therapy for ocular toxoplasmosisS Lam, H H TesslerThe British Journal of Ophthalmology|June 1, 1990
High-dose short-term chlorambucil for intractable sympathetic ophthalmia and Behçet's diseaseH H Tessler, T JenningsOphthalmic Surgery|February 1, 1993
Mitomycin as adjunct therapy in correcting iatrogenic punctal stenosisS Lam, H H TesslerDrug Intelligence & Clinical Pharmacy|September 1, 1985
Antimicrobial drug delivery to the eyeT S Lesar, R G FiscellaJournal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|January 1, 1996
Biotransformation in review: applications in ocular disease and drug designB I Gaynes, R G FiscellaPageof 11